472 related articles for article (PubMed ID: 26976653)
21. Vitamin D levels in Smith-Lemli-Opitz syndrome.
Movassaghi M; Bianconi S; Feinn R; Wassif CA; Porter FD
Am J Med Genet A; 2017 Oct; 173(10):2577-2583. PubMed ID: 28796426
[TBL] [Abstract][Full Text] [Related]
22. Mutations in the human sterol delta7-reductase gene at 11q12-13 cause Smith-Lemli-Opitz syndrome.
Wassif CA; Maslen C; Kachilele-Linjewile S; Lin D; Linck LM; Connor WE; Steiner RD; Porter FD
Am J Hum Genet; 1998 Jul; 63(1):55-62. PubMed ID: 9634533
[TBL] [Abstract][Full Text] [Related]
23. Analysis by liquid chromatography-mass spectrometry of sterols and oxysterols in brain of the newborn Dhcr7(Δ3-5/T93M) mouse: a model of Smith-Lemli-Opitz syndrome.
Meljon A; Watson GL; Wang Y; Shackleton CH; Griffiths WJ
Biochem Pharmacol; 2013 Jul; 86(1):43-55. PubMed ID: 23500538
[TBL] [Abstract][Full Text] [Related]
24. Sterol balance in the Smith-Lemli-Opitz syndrome. Reduction in whole body cholesterol synthesis and normal bile acid production.
Steiner RD; Linck LM; Flavell DP; Lin DS; Connor WE
J Lipid Res; 2000 Sep; 41(9):1437-47. PubMed ID: 10974051
[TBL] [Abstract][Full Text] [Related]
25. Oxysterols in the circulation of patients with the Smith-Lemli-Opitz syndrome: abnormal levels of 24S- and 27-hydroxycholesterol.
Björkhem I; Starck L; Andersson U; Lütjohann D; von Bahr S; Pikuleva I; Babiker A; Diczfalusy U
J Lipid Res; 2001 Mar; 42(3):366-71. PubMed ID: 11254748
[TBL] [Abstract][Full Text] [Related]
26. LC-MS/MS-based quantification of cholesterol and related metabolites in dried blood for the screening of inborn errors of sterol metabolism.
Becker S; Röhnike S; Empting S; Haas D; Mohnike K; Beblo S; Mütze U; Husain RA; Thiery J; Ceglarek U
Anal Bioanal Chem; 2015 Jul; 407(17):5227-33. PubMed ID: 25963649
[TBL] [Abstract][Full Text] [Related]
27. Diagnosis of Smith-Lemli-Opitz syndrome by ultraviolet spectrophotometry.
Scalco FB; Cruzes VM; Vendramini RC; Brunetti IL; Moretti-Ferreira D
Braz J Med Biol Res; 2003 Oct; 36(10):1327-32. PubMed ID: 14502364
[TBL] [Abstract][Full Text] [Related]
28. [Historical aspects of the Smith-Lemli-Opitz syndrome].
Bzdúch V; Behúlová D; Skodová J; Skokňová M; Kozák L
Cas Lek Cesk; 2014; 153(1):36-9. PubMed ID: 24506692
[TBL] [Abstract][Full Text] [Related]
29. DHCEO accumulation is a critical mediator of pathophysiology in a Smith-Lemli-Opitz syndrome model.
Xu L; Mirnics K; Bowman AB; Liu W; Da J; Porter NA; Korade Z
Neurobiol Dis; 2012 Mar; 45(3):923-9. PubMed ID: 22182693
[TBL] [Abstract][Full Text] [Related]
30. An efficient synthesis of 4α- and 4β-hydroxy- 7-dehydrocholesterol, biomarkers for patients with and animal models of the Smith-Lemli-Opitz syndrome.
Kawamoto H; Ohmori Y; Maekawa M; Shimada M; Mano N; Iida T
Chem Phys Lipids; 2013; 175-176():73-8. PubMed ID: 23920082
[TBL] [Abstract][Full Text] [Related]
31. No evidence for mevalonate shunting in moderately affected children with Smith-Lemli-Opitz syndrome.
Roullet JB; Merkens LS; Pappu AS; Jacobs MD; Winter R; Connor WE; Steiner RD
J Inherit Metab Dis; 2012 Sep; 35(5):859-69. PubMed ID: 22391996
[TBL] [Abstract][Full Text] [Related]
32. Direct analysis of sterols from dried plasma/blood spots by an atmospheric pressure thermal desorption chemical ionization mass spectrometry (APTDCI-MS) method for a rapid screening of Smith-Lemli-Opitz syndrome.
Paglia G; D'Apolito O; Gelzo M; Dello Russo A; Corso G
Analyst; 2010 Apr; 135(4):789-96. PubMed ID: 20349543
[TBL] [Abstract][Full Text] [Related]
33. A novel mutation of the DHCR7 gene in a sicilian compound heterozygote with Smith-Lemli-Opitz Syndrome.
Romano F; Fiore B; Pezzino FM; Longombardo MT; Cefalù AB; Noto D; Puglisi A; Brogna A; Mattina T; Averna M; Travali S
Mol Diagn; 2005; 9(4):201-4. PubMed ID: 16392899
[TBL] [Abstract][Full Text] [Related]
34. Biochemical and genetic aspects of 7-dehydrocholesterol reductase and Smith-Lemli-Opitz syndrome.
Waterham HR; Wanders RJ
Biochim Biophys Acta; 2000 Dec; 1529(1-3):340-56. PubMed ID: 11111101
[TBL] [Abstract][Full Text] [Related]
35. A placebo-controlled trial of simvastatin therapy in Smith-Lemli-Opitz syndrome.
Wassif CA; Kratz L; Sparks SE; Wheeler C; Bianconi S; Gropman A; Calis KA; Kelley RI; Tierney E; Porter FD
Genet Med; 2017 Mar; 19(3):297-305. PubMed ID: 27513191
[TBL] [Abstract][Full Text] [Related]
36. Smith-Lemli-Opitz syndrome: new mutation with a mild phenotype.
Prasad C; Marles S; Prasad AN; Nikkel S; Longstaffe S; Peabody D; Eng B; Wright S; Waye JS; Nowaczyk MJ
Am J Med Genet; 2002 Feb; 108(1):64-8. PubMed ID: 11857552
[TBL] [Abstract][Full Text] [Related]
37. Clinical and biochemical screening for Smith-Lemli-Opitz syndrome. Italian SLOS Collaborative Group.
Guzzetta V; De Fabiani E; Galli G; Colombo C; Corso G; Lecora M; Parenti G; Strisciuglio P; Andria G
Acta Paediatr; 1996 Aug; 85(8):937-42. PubMed ID: 8863875
[TBL] [Abstract][Full Text] [Related]
38. Effects of dietary cholesterol on plasma lipoproteins in Smith-Lemli-Opitz syndrome.
Merkens LS; Connor WE; Linck LM; Lin DS; Flavell DP; Steiner RD
Pediatr Res; 2004 Nov; 56(5):726-32. PubMed ID: 15319461
[TBL] [Abstract][Full Text] [Related]
39. Incidence of Smith-Lemli-Opitz syndrome in Ontario, Canada.
Nowaczyk MJ; McCaughey D; Whelan DT; Porter FD
Am J Med Genet; 2001 Jul; 102(1):18-20. PubMed ID: 11471166
[TBL] [Abstract][Full Text] [Related]
40. Cholesterol biosynthesis from birth to adulthood in a mouse model for 7-dehydrosterol reductase deficiency (Smith-Lemli-Opitz syndrome).
Marcos J; Shackleton CH; Buddhikot MM; Porter FD; Watson GL
Steroids; 2007 Oct; 72(11-12):802-8. PubMed ID: 17714750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
